Alliance Pharma plc (APH) Reaches New 1-Year High at $60.00
Shares of Alliance Pharma plc (LON:APH) reached a new 52-week high on Monday . The stock traded as high as GBX 60 ($0.79) and last traded at GBX 59.25 ($0.78), with a volume of 784,509 shares changing hands. The stock had previously closed at GBX 59.50 ($0.79).
APH has been the topic of several recent analyst reports. Numis Securities Ltd reiterated a “buy” rating and issued a GBX 60 ($0.79) price target on shares of Alliance Pharma plc in a report on Tuesday, July 18th. FinnCap reiterated a “buy” rating and issued a GBX 58 ($0.77) price target on shares of Alliance Pharma plc in a report on Thursday, September 14th. N+1 Singer reiterated a “not rated” rating on shares of Alliance Pharma plc in a report on Wednesday, September 13th. Finally, Investec initiated coverage on shares of Alliance Pharma plc in a report on Wednesday, September 13th. They issued a “buy” rating and a GBX 59 ($0.78) price target on the stock.
The company’s market cap is GBX 281.78 million. The firm’s 50 day moving average is GBX 55.11 and its 200-day moving average is GBX 52.24.
The firm also recently disclosed a dividend, which will be paid on Thursday, January 11th. Shareholders of record on Thursday, December 21st will be given a GBX 0.44 ($0.01) dividend. This represents a yield of 0.84%. The ex-dividend date of this dividend is Thursday, December 21st.
About Alliance Pharma plc
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.
Receive News & Stock Ratings for Alliance Pharma plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma plc and related stocks with our FREE daily email newsletter.